JPH11512442A5 - - Google Patents

Info

Publication number
JPH11512442A5
JPH11512442A5 JP1997512335A JP51233597A JPH11512442A5 JP H11512442 A5 JPH11512442 A5 JP H11512442A5 JP 1997512335 A JP1997512335 A JP 1997512335A JP 51233597 A JP51233597 A JP 51233597A JP H11512442 A5 JPH11512442 A5 JP H11512442A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997512335A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11512442A (ja
JP4824147B2 (ja
Filing date
Publication date
Priority claimed from GBGB9519197.9A external-priority patent/GB9519197D0/en
Application filed filed Critical
Publication of JPH11512442A publication Critical patent/JPH11512442A/ja
Publication of JPH11512442A5 publication Critical patent/JPH11512442A5/ja
Application granted granted Critical
Publication of JP4824147B2 publication Critical patent/JP4824147B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP51233597A 1995-09-20 1996-09-19 新規な親和性リガンド類およびそれらの用途 Expired - Lifetime JP4824147B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9519197.9 1995-09-20
GBGB9519197.9A GB9519197D0 (en) 1995-09-20 1995-09-20 Novel affinity ligands and their use
PCT/DK1996/000399 WO1997010887A1 (en) 1995-09-20 1996-09-19 Novel affinity ligands and their use

Publications (3)

Publication Number Publication Date
JPH11512442A JPH11512442A (ja) 1999-10-26
JPH11512442A5 true JPH11512442A5 (https=) 2004-09-30
JP4824147B2 JP4824147B2 (ja) 2011-11-30

Family

ID=10780990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51233597A Expired - Lifetime JP4824147B2 (ja) 1995-09-20 1996-09-19 新規な親和性リガンド類およびそれらの用途

Country Status (16)

Country Link
EP (1) EP0959975B1 (https=)
JP (1) JP4824147B2 (https=)
KR (1) KR100537386B1 (https=)
CN (1) CN1089617C (https=)
AR (1) AR003634A1 (https=)
AT (1) ATE285827T1 (https=)
AU (1) AU702901B2 (https=)
CA (1) CA2232626C (https=)
DE (1) DE69634142T2 (https=)
DK (1) DK0959975T3 (https=)
ES (1) ES2236748T3 (https=)
GB (1) GB9519197D0 (https=)
MY (1) MY127957A (https=)
RU (1) RU2175261C2 (https=)
WO (1) WO1997010887A1 (https=)
ZA (1) ZA967917B (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760187A (en) * 1996-02-22 1998-06-02 Mitsui Toatsu Chemicals, Inc. Purification process of a human growth hormone
US6498236B1 (en) * 1996-08-30 2002-12-24 Upfront Chromatography A/S Isolation of immunoglobulins
EP0945447A1 (en) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
GB9910807D0 (en) * 1999-05-10 1999-07-07 Prometic Biosciences Limited Novel detoxification agents and their use
TR200200763T2 (tr) 1999-09-24 2003-09-22 Janssen Pharmaceutica N.V. Antiviral bileşimler
US6153365A (en) 1999-12-16 2000-11-28 Eastman Kodak Company Photographic processing compositions containing stain reducing agent
US6153364A (en) * 1999-12-16 2000-11-28 Eastman Kodak Company Photographic processing methods using compositions containing stain reducing agent
AU2001259293A1 (en) * 2000-04-28 2001-11-12 Accurate Polymers, Inc. Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
US6288227B1 (en) 2000-10-05 2001-09-11 Eastman Kodak Company Solublized 2,6-dinaphthylaminotriazines
US6440651B1 (en) 2000-10-05 2002-08-27 Eastman Kodak Company Concentrated photographic fixer additive and fixing compositions and method of photographic processing
WO2002072561A1 (en) * 2001-01-26 2002-09-19 Smithkline Beecham Corporation Piperazinyltriazines as estrogen receptor modulators
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
GB0224446D0 (en) * 2002-10-21 2002-11-27 Univ Cambridge Tech Affinity adsorbents for immunoglobulins
GB0228724D0 (en) 2002-12-09 2003-01-15 Prometic Biosciences Ltd Multidimensinal libraries
US7109040B2 (en) * 2002-12-13 2006-09-19 Agilent Technologies, Inc. Modular isotope coding approach to proteomic analysis
US7700743B2 (en) * 2003-07-22 2010-04-20 Millipore Corporation Immobilised affinity medium and its use in separation
KR101150050B1 (ko) * 2004-02-27 2012-07-05 지이 헬스케어 바이오-사이언시스 에이비 항체 정제 방법
SE0400501D0 (sv) * 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
SE0401665D0 (sv) * 2004-06-24 2004-06-24 Amersham Biosciences Ab Purification of immunoglobulins
GB0416699D0 (en) * 2004-07-27 2004-09-01 Prometic Biosciences Ltd Prion protein ligands and methods of use
WO2006024175A1 (en) * 2004-09-03 2006-03-09 Prometic Biosciences Inc. 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE
CA2583578C (en) * 2004-10-21 2014-04-01 Ge Healthcare Bio-Sciences Ab Chromatography ligand
CA2591785A1 (en) * 2004-12-23 2006-06-29 Novo Nordisk A/S Antibody binding affinity ligands
EP2360171A1 (en) 2004-12-23 2011-08-24 Novo Nordisk Health Care AG Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest
GB0509443D0 (en) * 2005-05-09 2005-06-15 Prometic Biosciences Ltd Affinity adsorbents for factor VIII and von willebrand's factor
GB0509442D0 (en) * 2005-05-09 2005-06-15 Prometic Biosciences Ltd Affinity adsorbents for fibrinogen
GB0509438D0 (en) * 2005-05-09 2005-06-15 Prometic Biosciences Ltd Affinity adsorbets for fibrinogen
WO2006131768A2 (en) * 2005-06-10 2006-12-14 Prometic Biosciences Limited Triazines as protein binding ligands
US20080220968A1 (en) * 2005-07-05 2008-09-11 Ge Healthcare Bio-Sciences Ab [1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg
GB0604236D0 (en) * 2006-03-02 2006-04-12 Prometic Biosciences Ltd Adsorbents for protein purification
EP2139573B1 (en) 2007-03-28 2016-11-09 DPx Holdings B.V. Expanded bed column and disposable chromatography
JP5450381B2 (ja) 2007-04-30 2014-03-26 プロメティック・バイオサイエンスィズ・インコーポレーテッド 化合物、そのような化合物を含有する組成物、及びそのような化合物を用いるがん及び自己免疫疾患の治療法
GB0808908D0 (en) * 2008-05-16 2008-06-25 Avecia Biolog Ltd Purification process
MX353308B (es) 2008-05-21 2018-01-08 Ariad Pharma Inc Derivados fosforosos como inhibidores de cinasa.
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
WO2010055135A1 (en) * 2008-11-13 2010-05-20 Novo Nordisk A/S Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands
PT2419732T (pt) 2009-04-15 2019-12-24 Abraxis Bioscience Llc Composições e métodos de nanopartículas isentas de priões
DK2427486T3 (en) 2009-05-07 2015-05-26 Novozymes Biopharma Dk As A process for purifying albumin
EP2440548A1 (en) 2009-06-10 2012-04-18 Abbott Laboratories 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
WO2011012302A1 (en) * 2009-07-28 2011-02-03 Instraction Gmbh Specific sorbent for binding proteins and peptides, and separation method using the same
WO2011037610A1 (en) * 2009-09-23 2011-03-31 Albert Einstein College Of Medicine Of Yeshiva University Prostaglandin transporter inhibitors and uses thereof
US9273151B2 (en) 2011-03-24 2016-03-01 Kaneka Corporation Proteinaceous-substance-binding low-molecular-weight compound
EP2704572B1 (en) 2011-05-04 2015-12-30 Ariad Pharmaceuticals, Inc. Compounds for inhibiting cell proliferation in egfr-driven cancers
WO2013169401A1 (en) 2012-05-05 2013-11-14 Ariad Pharmaceuticals, Inc. Compounds for inhibiting cell proliferation in egfr-driven cancers
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
GB2513405A (en) * 2013-04-26 2014-10-29 Adc Biotechnology Ltd Method of synthesising ADCs using affinity resins
CN104148018B (zh) * 2013-05-14 2018-04-20 上海亨臻实业有限公司 抗体亲和纯化材料及其用途
EP2918641A1 (en) 2014-03-13 2015-09-16 Basf Se Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures
GB201419185D0 (en) 2014-10-28 2014-12-10 Adc Biotechnology Ltd Method of synthesising ADCs using affinity resin
GB201419184D0 (en) 2014-10-28 2014-12-10 Adc Biotechnology Ltd Method of synthesising biomolecule-effector/reporter-conjugates using affinity resins
RU2627849C1 (ru) * 2016-07-22 2017-08-14 Игорь Анатольевич Мнушкин Способ разделения газового потока на отдельные компоненты или фракции
RU2626354C9 (ru) * 2016-07-25 2017-10-04 Игорь Анатольевич Мнушкин Способ разделения газового потока на отдельные компоненты или фракции
CN109354600B (zh) * 2018-11-29 2021-08-10 浙江海洋大学 一种牛磺酸修饰的新型阿拉斯加鳕鱼多功能肽的制备方法
CN113527284B (zh) * 2021-07-16 2024-08-06 东莞市顶盛环保科技有限公司 一种含双酯基均三嗪衍生物的环保多功能材料及其制备方法与应用
CN113563324B (zh) * 2021-07-22 2024-08-06 东莞市顶盛环保科技有限公司 一种含酯基均三嗪的绿色环保多功能材料及其制备方法与应用
CN118719009B (zh) * 2024-07-18 2025-02-14 山东微领生物有限公司 一种层析介质改性方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726019A1 (de) * 1987-08-05 1989-02-16 Boehringer Mannheim Gmbh Verfahren zur abtrennung und reinigung von t-pa

Similar Documents

Publication Publication Date Title
JP2000500033A5 (https=)
JP2000500445A5 (https=)
JP2000500228A5 (https=)
JP2000500440A5 (https=)
JP2000500327A5 (https=)
JP2000500145A5 (https=)
JP2000500155A5 (https=)
JP2000500406A5 (https=)
JP2000500361A5 (https=)
JP2000500115A5 (https=)
JP2000500322A5 (https=)
JP2000500258A5 (https=)
JP2000500342A5 (https=)
JP2000500192A5 (https=)
JP2000500112A5 (https=)
JP2000500226A5 (https=)
JP2000500051A5 (https=)
JP2000500397A5 (https=)
JP2000500407A5 (https=)
JP2000500166A5 (https=)
JP2000500019A5 (https=)
JP2000500125A5 (https=)
JP2000500044A5 (https=)
JP2000500346A5 (https=)
JP2000500090A5 (https=)